INS and type 2 diabetes mellitus: Miguel-Escalada and colleague [68] constructed an islet-specific T2D PRS using islet enhancer hub variants involved in islet gene regulation and insulin secretion and showed its potential in delineating T2D risk profiles from the novel perspective of tissue-specific epigenomic mechanisms.